The Cooper Companies, Inc. (NASDAQ: COO) Stock Competitors & Peer Comparison
See COO's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for COO and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| COO | $75.76 | +0.88% | 14.8B | 16.61 | $4.56 | N/A |
| ISRG | $391.18 | +0.22% | 138.2B | 40.66 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.05% |
| BDX | $180.77 | -1.43% | 50.2B | 14.01 | $13.00 | +2.05% |
| MDLN | $34.12 | -2.18% | 28.9B | 25.00 | $1.36 | N/A |
| WST | $346.59 | -0.01% | 24.4B | 43.50 | $7.97 | +0.25% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $87.45 | +0.73% | 15.1B | 12.31 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.05% |
| BAX | $25.94 | -2.96% | 13.4B | 12.46 | $2.08 | +0.77% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
COO vs ISRG Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, ISRG has a market cap of 138.2B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while ISRG trades at $391.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas ISRG's P/E ratio is 40.66. In terms of profitability, COO's ROE is +0.03%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, COO is less volatile compared to ISRG. This indicates lower risk in terms of short-term price fluctuations for COO.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
COO vs BDXA Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas BDXA's P/E ratio is 45.70. In terms of profitability, COO's ROE is +0.03%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, COO is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for COO.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
COO vs BDX Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, BDX has a market cap of 50.2B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while BDX trades at $180.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas BDX's P/E ratio is 14.01. In terms of profitability, COO's ROE is +0.03%, compared to BDX's ROE of +0.04%. Regarding short-term risk, COO is less volatile compared to BDX. This indicates lower risk in terms of short-term price fluctuations for COO.Check BDX's competition here
Medline Inc. (NASDAQ: MDLN)
COO vs MDLN Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, MDLN has a market cap of 28.9B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while MDLN trades at $34.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas MDLN's P/E ratio is 25.00. In terms of profitability, COO's ROE is +0.03%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, COO is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for COO.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
COO vs WST Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, WST has a market cap of 24.4B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while WST trades at $346.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas WST's P/E ratio is 43.50. In terms of profitability, COO's ROE is +0.03%, compared to WST's ROE of +0.19%. Regarding short-term risk, COO is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for COO.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
COO vs HOLX Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas HOLX's P/E ratio is 31.54. In terms of profitability, COO's ROE is +0.03%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, COO is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for COO.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
COO vs SOLV Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, SOLV has a market cap of 15.1B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while SOLV trades at $87.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas SOLV's P/E ratio is 12.31. In terms of profitability, COO's ROE is +0.03%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, COO is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for COO.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
COO vs BDXB Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas BDXB's P/E ratio is 7.60. In terms of profitability, COO's ROE is +0.03%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, COO is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for COO.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
COO vs BAX Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, BAX has a market cap of 13.4B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while BAX trades at $25.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas BAX's P/E ratio is 12.46. In terms of profitability, COO's ROE is +0.03%, compared to BAX's ROE of -0.17%. Regarding short-term risk, COO is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for COO.Check BAX's competition here
Repligen Corporation (NASDAQ: RGEN)
COO vs RGEN Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, RGEN has a market cap of 9.4B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while RGEN trades at $166.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas RGEN's P/E ratio is 92.31. In terms of profitability, COO's ROE is +0.03%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, COO is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for COO.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
COO vs AVTR Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, AVTR has a market cap of 9B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while AVTR trades at $13.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas AVTR's P/E ratio is 15.72. In terms of profitability, COO's ROE is +0.03%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, COO is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for COO.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
COO vs ATR Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, ATR has a market cap of 8.4B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while ATR trades at $131.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas ATR's P/E ratio is 23.03. In terms of profitability, COO's ROE is +0.03%, compared to ATR's ROE of +0.14%. Regarding short-term risk, COO is less volatile compared to ATR. This indicates lower risk in terms of short-term price fluctuations for COO.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
COO vs BLCO Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, BLCO has a market cap of 6.1B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while BLCO trades at $17.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas BLCO's P/E ratio is 26.12. In terms of profitability, COO's ROE is +0.03%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, COO is less volatile compared to BLCO. This indicates lower risk in terms of short-term price fluctuations for COO.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
COO vs TFX Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, TFX has a market cap of 5.8B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while TFX trades at $131.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas TFX's P/E ratio is 15.08. In terms of profitability, COO's ROE is +0.03%, compared to TFX's ROE of -0.32%. Regarding short-term risk, COO is less volatile compared to TFX. This indicates lower risk in terms of short-term price fluctuations for COO.Check TFX's competition here
Stevanato Group S.p.A. (NYSE: STVN)
COO vs STVN Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, STVN has a market cap of 5.8B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while STVN trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas STVN's P/E ratio is 32.13. In terms of profitability, COO's ROE is +0.03%, compared to STVN's ROE of +0.09%. Regarding short-term risk, COO is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for COO.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
COO vs MMSI Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, MMSI has a market cap of 5.3B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while MMSI trades at $89.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas MMSI's P/E ratio is 22.83. In terms of profitability, COO's ROE is +0.03%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, COO is less volatile compared to MMSI. This indicates lower risk in terms of short-term price fluctuations for COO.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
COO vs ICUI Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, ICUI has a market cap of 4.6B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while ICUI trades at $183.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas ICUI's P/E ratio is 22.94. In terms of profitability, COO's ROE is +0.03%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, COO is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for COO.Check ICUI's competition here
Envista Holdings Corp (NYSE: NVST)
COO vs NVST Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, NVST has a market cap of 4.5B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while NVST trades at $27.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas NVST's P/E ratio is 18.93. In terms of profitability, COO's ROE is +0.03%, compared to NVST's ROE of +0.04%. Regarding short-term risk, COO is less volatile compared to NVST. This indicates lower risk in terms of short-term price fluctuations for COO.Check NVST's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
COO vs PLSE Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, PLSE has a market cap of 3.2B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while PLSE trades at $46.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas PLSE's P/E ratio is -38.98. In terms of profitability, COO's ROE is +0.03%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, COO is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for COO.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
COO vs ATRC Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, ATRC has a market cap of 2.3B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while ATRC trades at $45.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas ATRC's P/E ratio is 1421.12. In terms of profitability, COO's ROE is +0.03%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, COO is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for COO.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
COO vs XRAY Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, XRAY has a market cap of 2.2B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while XRAY trades at $11.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas XRAY's P/E ratio is 7.77. In terms of profitability, COO's ROE is +0.03%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, COO is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for COO.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
COO vs LMAT Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while LMAT trades at $81.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas LMAT's P/E ratio is 29.97. In terms of profitability, COO's ROE is +0.03%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, COO is less volatile compared to LMAT. This indicates lower risk in terms of short-term price fluctuations for COO.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
COO vs BLFS Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, BLFS has a market cap of 1.7B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while BLFS trades at $34.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas BLFS's P/E ratio is -167.73. In terms of profitability, COO's ROE is +0.03%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, COO is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for COO.Check BLFS's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
COO vs KMTS Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, KMTS has a market cap of 1.6B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while KMTS trades at $27.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas KMTS's P/E ratio is -11.83. In terms of profitability, COO's ROE is +0.03%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, COO is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for COO.Check KMTS's competition here
Azenta, Inc. (NASDAQ: AZTA)
COO vs AZTA Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, AZTA has a market cap of 1.5B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while AZTA trades at $32.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas AZTA's P/E ratio is 79.95. In terms of profitability, COO's ROE is +0.03%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, COO is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for COO.Check AZTA's competition here
STAAR Surgical Company (NASDAQ: STAA)
COO vs STAA Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while STAA trades at $24.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas STAA's P/E ratio is 43.23. In terms of profitability, COO's ROE is +0.03%, compared to STAA's ROE of +0.01%. Regarding short-term risk, COO is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for COO.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
COO vs QDEL Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, QDEL has a market cap of 915.8M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while QDEL trades at $13.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas QDEL's P/E ratio is 10.02. In terms of profitability, COO's ROE is +0.03%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, COO is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for COO.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
COO vs ATRI Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas ATRI's P/E ratio is 64.50. In terms of profitability, COO's ROE is +0.03%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, COO is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for COO.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
COO vs ANGO Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, ANGO has a market cap of 653.9M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while ANGO trades at $15.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas ANGO's P/E ratio is -40.56. In terms of profitability, COO's ROE is +0.03%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, COO is less volatile compared to ANGO. This indicates lower risk in terms of short-term price fluctuations for COO.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
COO vs NNNN Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, NNNN has a market cap of 366.5M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while NNNN trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas NNNN's P/E ratio is 120.66. In terms of profitability, COO's ROE is +0.03%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, COO is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for COO.Check NNNN's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
COO vs SMTI Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, SMTI has a market cap of 314.1M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while SMTI trades at $34.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas SMTI's P/E ratio is -569.50. In terms of profitability, COO's ROE is +0.03%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, COO is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for COO.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
COO vs OSUR Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, OSUR has a market cap of 258.2M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while OSUR trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas OSUR's P/E ratio is -6.82. In terms of profitability, COO's ROE is +0.03%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, COO is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for COO.Check OSUR's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
COO vs INFU Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, INFU has a market cap of 246.4M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while INFU trades at $12.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas INFU's P/E ratio is 29.78. In terms of profitability, COO's ROE is +0.03%, compared to INFU's ROE of +0.15%. Regarding short-term risk, COO is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for COO.Check INFU's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
COO vs UTMD Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, UTMD has a market cap of 229.3M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while UTMD trades at $72.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas UTMD's P/E ratio is 21.30. In terms of profitability, COO's ROE is +0.03%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, COO is less volatile compared to UTMD. This indicates lower risk in terms of short-term price fluctuations for COO.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
COO vs PDEX Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, PDEX has a market cap of 213.6M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while PDEX trades at $66.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas PDEX's P/E ratio is 23.55. In terms of profitability, COO's ROE is +0.03%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, COO is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for COO.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
COO vs KRMD Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, KRMD has a market cap of 153M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while KRMD trades at $3.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas KRMD's P/E ratio is -83.25. In terms of profitability, COO's ROE is +0.03%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, COO is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for COO.Check KRMD's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
COO vs MBOT Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, MBOT has a market cap of 67M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while MBOT trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas MBOT's P/E ratio is -5.65. In terms of profitability, COO's ROE is +0.03%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, COO is less volatile compared to MBOT. This indicates lower risk in terms of short-term price fluctuations for COO.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
COO vs AKYA Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas AKYA's P/E ratio is -1.34. In terms of profitability, COO's ROE is +0.03%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, COO is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for COO.Check AKYA's competition here
Daxor Corporation (NASDAQ: DXR)
COO vs DXR Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, DXR has a market cap of 57.2M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while DXR trades at $10.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas DXR's P/E ratio is 25.63. In terms of profitability, COO's ROE is +0.03%, compared to DXR's ROE of +0.22%. Regarding short-term risk, COO is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for COO.Check DXR's competition here
SkyAI, Inc. (NASDAQ: STSS)
COO vs STSS Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas STSS's P/E ratio is -0.02. In terms of profitability, COO's ROE is +0.03%, compared to STSS's ROE of -1.54%. Regarding short-term risk, COO is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for COO.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
COO vs OMIC Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas OMIC's P/E ratio is -0.58. In terms of profitability, COO's ROE is +0.03%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, COO is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for COO.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
COO vs IGAP Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas IGAP's P/E ratio is -10.52. In terms of profitability, COO's ROE is +0.03%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, COO is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for COO.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
COO vs NEPH Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, NEPH has a market cap of 49.8M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while NEPH trades at $4.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas NEPH's P/E ratio is 76.50. In terms of profitability, COO's ROE is +0.03%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, COO is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for COO.Check NEPH's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
COO vs POCI Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, POCI has a market cap of 47.4M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while POCI trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas POCI's P/E ratio is -6.02. In terms of profitability, COO's ROE is +0.03%, compared to POCI's ROE of -0.37%. Regarding short-term risk, COO is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for COO.Check POCI's competition here
Milestone Scientific Inc. (AMEX: MLSS)
COO vs MLSS Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, MLSS has a market cap of 43.3M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while MLSS trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas MLSS's P/E ratio is -8.16. In terms of profitability, COO's ROE is +0.03%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, COO is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for COO.Check MLSS's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
COO vs HBIO Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, HBIO has a market cap of 31.4M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while HBIO trades at $6.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas HBIO's P/E ratio is -19.36. In terms of profitability, COO's ROE is +0.03%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, COO is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for COO.Check HBIO's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
COO vs SDC Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas SDC's P/E ratio is -0.03. In terms of profitability, COO's ROE is +0.03%, compared to SDC's ROE of -1.96%. Regarding short-term risk, COO is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for COO.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
COO vs IVC Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas IVC's P/E ratio is -0.79. In terms of profitability, COO's ROE is +0.03%, compared to IVC's ROE of -0.46%. Regarding short-term risk, COO is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for COO.Check IVC's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
COO vs ZJYL Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, ZJYL has a market cap of 24.1M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while ZJYL trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas ZJYL's P/E ratio is 19.25. In terms of profitability, COO's ROE is +0.03%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, COO is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for COO.Check ZJYL's competition here
Retractable Technologies, Inc. (AMEX: RVP)
COO vs RVP Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, RVP has a market cap of 21.7M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while RVP trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas RVP's P/E ratio is -2.20. In terms of profitability, COO's ROE is +0.03%, compared to RVP's ROE of -0.05%. Regarding short-term risk, COO is less volatile compared to RVP. This indicates lower risk in terms of short-term price fluctuations for COO.Check RVP's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
COO vs RGNT Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, RGNT has a market cap of 14M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while RGNT trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas RGNT's P/E ratio is -0.08. In terms of profitability, COO's ROE is +0.03%, compared to RGNT's ROE of N/A. Regarding short-term risk, COO is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for COO.Check RGNT's competition here
Femasys Inc. (NASDAQ: FEMY)
COO vs FEMY Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, FEMY has a market cap of 6.6M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while FEMY trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas FEMY's P/E ratio is -6.08. In terms of profitability, COO's ROE is +0.03%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, COO is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for COO.Check FEMY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
COO vs NSTG Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas NSTG's P/E ratio is -0.03. In terms of profitability, COO's ROE is +0.03%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, COO is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for COO.Check NSTG's competition here
Lucyd, Inc (NASDAQ: LUCY)
COO vs LUCY Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, LUCY has a market cap of 4.5M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while LUCY trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas LUCY's P/E ratio is -0.43. In terms of profitability, COO's ROE is +0.03%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, COO is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for COO.Check LUCY's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
COO vs POAI Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas POAI's P/E ratio is -0.03. In terms of profitability, COO's ROE is +0.03%, compared to POAI's ROE of -21.19%. Regarding short-term risk, COO is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for COO.Check POAI's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
COO vs NXGL Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, NXGL has a market cap of 3.3M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while NXGL trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas NXGL's P/E ratio is -0.55. In terms of profitability, COO's ROE is +0.03%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, COO is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for COO.Check NXGL's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
COO vs GCTK Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, GCTK has a market cap of 2.6M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while GCTK trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas GCTK's P/E ratio is -0.02. In terms of profitability, COO's ROE is +0.03%, compared to GCTK's ROE of -21.36%. Regarding short-term risk, COO is less volatile compared to GCTK. This indicates lower risk in terms of short-term price fluctuations for COO.Check GCTK's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
COO vs MHUA Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas MHUA's P/E ratio is 0.25. In terms of profitability, COO's ROE is +0.03%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, COO is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for COO.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
COO vs GMVD Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas GMVD's P/E ratio is -0.01. In terms of profitability, COO's ROE is +0.03%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, COO is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for COO.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
COO vs GMVDW Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas GMVDW's P/E ratio is N/A. In terms of profitability, COO's ROE is +0.03%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, COO is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for COO.Check GMVDW's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
COO vs NXGLW Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, NXGLW has a market cap of 1.5M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas NXGLW's P/E ratio is -0.05. In terms of profitability, COO's ROE is +0.03%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, COO is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for COO.Check NXGLW's competition here
Avinger, Inc. (NASDAQ: AVGR)
COO vs AVGR Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas AVGR's P/E ratio is -0.05. In terms of profitability, COO's ROE is +0.03%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, COO is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for COO.Check AVGR's competition here
Lucyd, Inc (NASDAQ: LUCYW)
COO vs LUCYW Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas LUCYW's P/E ratio is N/A. In terms of profitability, COO's ROE is +0.03%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, COO is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for COO.Check LUCYW's competition here
Apria, Inc. (NASDAQ: APR)
COO vs APR Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, APR has a market cap of 0. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas APR's P/E ratio is 22.59. In terms of profitability, COO's ROE is +0.03%, compared to APR's ROE of +9.81%. Regarding short-term risk, COO is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for COO.Check APR's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
COO vs HRC Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, HRC has a market cap of 0. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas HRC's P/E ratio is 41.92. In terms of profitability, COO's ROE is +0.03%, compared to HRC's ROE of +0.14%. Regarding short-term risk, COO is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for COO.Check HRC's competition here
IntriCon Corporation (NASDAQ: IIN)
COO vs IIN Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, IIN has a market cap of 0. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas IIN's P/E ratio is 226.45. In terms of profitability, COO's ROE is +0.03%, compared to IIN's ROE of -0.00%. Regarding short-term risk, COO is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for COO.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
COO vs ALOG Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas ALOG's P/E ratio is 40.93. In terms of profitability, COO's ROE is +0.03%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, COO is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for COO.Check ALOG's competition here
Invuity, Inc. (NASDAQ: IVTY)
COO vs IVTY Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas IVTY's P/E ratio is -3.80. In terms of profitability, COO's ROE is +0.03%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, COO is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for COO.Check IVTY's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
COO vs ATRS Comparison August 2026
The Cooper Companies, Inc. (NASDAQ: COO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COO stands at 14.8B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, COO is priced at $75.76 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COO currently has a P/E ratio of 16.61, whereas ATRS's P/E ratio is 14.95. In terms of profitability, COO's ROE is +0.03%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, COO is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for COO.Check ATRS's competition here